Vibrasense, developed by Ayati Devices, is transforming healthcare with its innovative solutions for neuropathy and diabetes-related foot complications. Founded on February 9, 2019, Vibrasense is dedicated to bringing actionable, impactful, and non-invasive healthcare products to society.
Their strong research foundation and support from SINE, IIT Bombay, along with receiving the BIRAC BIG Grant by the Government of India, highlight their credibility. Vibrasense Shark Tank India Season 4 led to a significant investment, propelling their growth in the medical technology sector.
Know about Vibrasense
Vibrasense is a pioneering neuropathy detection device designed to help individuals identify early signs of diabetes-induced foot complications. Key features include:
- Non-Invasive Technology: Early detection without any discomfort.
- Accurate & Actionable Insights: Provides critical diagnostic data to aid in timely intervention.
- Clinically Validated: Backed by research and incubated at SINE, IIT Bombay.
Their mission is to provide affordable and accessible solutions for millions suffering from diabetic neuropathy.
You can also check the BurgerBae Shark Tank India Season 4 pitch.
Vibrasense Pitch on Shark Tank India Season 4
On Shark Tank India Season 4, the founders of Vibrasense highlighted the rising concern of diabetes-related neuropathy and how their device can prevent severe complications through early detection. Their commitment to clinical research, innovation, and patient well-being resonated with the Sharks.
Investment Details
| Company | Vibrasense |
| Founders | Nishant Kathpal |
| Website | https://www.vibrasense.in/ |
| Season | Shark Tank India Season 4 |
| Original Ask | ₹ 1 Crore for 2% Equity at a ₹50 Crore Valuation |
| Investment Secured | Yes |
| Deal | ₹ 1 Crore for 4.76% Equity |
| Investor | Namita Thapar and Peyush Bansal |
Vibrasense Winning Moment Shark Tank India
Namita Thapar and Peyush Bansal recognized the life-changing potential of Vibrasense and offered ₹ 1 Crore for 4.76% equity. Their investment will support scaling production, expanding research, and increasing accessibility to Vibrasense’s technology.
Why Vibrasense Stands Out
- Revolutionary Healthcare Tech: Provides a non-invasive and early detection system for neuropathy.
- Clinically Approved & Incubated: Backed by SINE, IIT Bombay and government grants.
- Growing Market Need: Addresses a critical healthcare challenge affecting millions.
What’s Next for Vibrasense?
With investment from Namita Thapar and Peyush Bansal, Vibrasense plans to:
- Expand clinical trials to further validate and improve its technology.
- Increase production to make the device widely available across healthcare facilities.
- Collaborate with hospitals and healthcare providers for wider adoption.